Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Szmuness Hepatitis B Vaccine Trial
NCT00000583Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Nov 1978
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of Heptavax-B in hepatitis B (HBV), sponsored by National Heart, Lung, and Blood Institute. Started Nov 1978; status: completed.
02
Drugs
Heptavax-B
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00000583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000583.